ECM Therapeutics
Warrendale
About ECM Therapeutics
ECM Therapeutics is a regenerative medicine company that develops natural biomaterial to treat disease and injury. The company also develops and manufactures diagnostic and therapeutic products derived from a naturally occurring material called extracellular matrix (ECM). It provides cues for cell attachment, migration, proliferation, and 3-D spatial organization. ECM Therapeutics' patented ECM hydrogel technology allows for expanded, less invasive applications in multiple disease areas. It utilizes the body’s own template to restore naturally occurring functional tissue following injury. ECM Therapeutics was founded in 2018 and is based in Warrendale, Pennsylvania, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $35.2M
- Last round: Series Unknown (Jun 2018)
- Website: ecmtherapeutics.com
- Phone: +1 814-325-2328
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/ecm-therapeutics-53556 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.